Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hormonal Contraceptives
Pharma
Bayer scores €3B capital equity infusion in deal with Apollo
Bayer has signed a deal to secure 3B euros in equity with Apollo, surrendering a minority, non-controlling stake in its contraceptives business.
Kevin Dunleavy
Jul 10, 2026 11:31am
Contraline gins up $92.5M in male birth control development push
Jun 2, 2026 8:00am
Perrigo launches OTC birth control pill in the US
Mar 4, 2024 11:10am
Agile teams with soccer star Lloyd on women's health campaign
Oct 5, 2021 3:30pm
Bayer debuts first dual IUD ad for Mirena and Kyleena
Feb 22, 2019 11:23am
Doctor alerts Allergan to package issue for contraceptive pills
May 29, 2018 8:30pm
